SCHEMBL6220184

SCHEMBL6220184

Cc1nc(N)cnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14611549 0.81
SCHEMBL30060684 0.77
SCHEMBL2033970 0.77
SCHEMBL8257576 0.77
SCHEMBL2414672 0.75
SCHEMBL10255501 0.75
SCHEMBL4883086 0.75
SCHEMBL841270 0.75
SCHEMBL29625025 0.75
SCHEMBL8919061 0.73 CDK2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1307179-C pyrimidine derivatives for inhibiting cell proliferation ASTRAZENECA AB (SE) 2007-03-28 CN disclosed
EP-1362050-B1 PYRIMIDINE DERIVATIVES FOR INHIBITION OF CELL-PROLIFERATION ASTRAZENECA AB (SE) 2005-02-02 EP disclosed
US-6844341-B2 Pyrimidine derivatives for inhibition of cell proliferation ASTRAZENECA AB (SE) 2005-01-18 US disclosed
CN-1524081-A Pyrimidine derivatives for inhibition of cell proliferation 2004-08-25 CN disclosed
US-20040097506-A1 Pyrimidine derivatives for inhibition of cell proliferation ASTRAZENECA AB (SE) 2004-05-20 US disclosed
EP-1362050-A1 PYRIMIDINE DERIVATIVES FOR INHIBITION OF CELL-PROLIFERATION AstraZeneca AB (SE) 2003-11-19 EP disclosed
WO-2002066481-A1 PYRIMIDINE DERIVATIVES FOR INHIBITION OF CELL-PROLIFERATION ASTRAZENECA AB (SE) 2002-08-29 WO disclosed